Genentech Looking To Expand R&D Efforts To New Therapeutic Areas In 2007
Executive Summary
Genentech is considering options to expand its reach into therapeutic areas beyond oncology and immunology, according to CEO Art Levinson
You may also be interested in...
Schering Jumps On Organon Buy; Will Late-Stage M&A Keep Fueling Pharma?
Pharmaceutical companies unveiling mergers and acquisitions in the first quarter were among those rewarded by Wall Street
Schering Jumps On Organon Buy; Will Late-Stage M&A Keep Fueling Pharma?
Pharmaceutical companies unveiling mergers and acquisitions in the first quarter were among those rewarded by Wall Street
Avastin Duration Of Use In NSCLC May Increase Alongside Promotional Efforts
Duration of use for Avastin in lung cancer may increase with continued promotion of the indication, according to Genentech